Develops drugs for neurological diseases.
Dec 2025Revenue $130K/yrExpenses $24.2M/yr
No trendCash runway ≈ 1.1 years from Jun 2026
Figures by year
When will Serina Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $130K and expenses $24.2M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $130K | $24.2M | −$24.0M |
| Dec 2024 | $56.0K | $17.1M | −$17.0M |
| Dec 2023 | $3.15M | $6.28M | −$3.13M |
| Dec 2022 | $34.0K | $7.01M | −$6.97M |
| Dec 2021 | $144K | $8.08M | −$7.93M |
| Dec 2020 | $361K | $10.5M | −$10.1M |
| Dec 2019 | $1.73M | $14.3M | −$12.6M |
| Dec 2018 | $1.40M | $12.6M | −$11.2M |
| Dec 2017 | $1.40M | $8.07M | −$6.66M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.